Compare ARTNA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARTNA | BCYC |
|---|---|---|
| Founded | 1905 | 2009 |
| Country | United States | United Kingdom |
| Employees | 274 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 291.8M |
| IPO Year | N/A | 2019 |
| Metric | ARTNA | BCYC |
|---|---|---|
| Price | $34.36 | $4.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $13.90 |
| AVG Volume (30 Days) | 26.2K | ★ 362.0K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.82 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | $15.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.50 | $3.87 |
| 52 Week High | $34.90 | $9.16 |
| Indicator | ARTNA | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 38.59 |
| Support Level | $31.87 | $3.94 |
| Resistance Level | $34.86 | $4.52 |
| Average True Range (ATR) | 0.75 | 0.18 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 69.66 | 13.91 |
Artesian Resources Corp operates as a holding company based in the United States. Through its subsidiaries, it offers water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The Group distributes and sells water, including water for public and private fire protection, to residential, commercial, industrial, municipal, and utility customers. Additionally, it is involved in contract water and wastewater operations; offers wastewater services, and water, sewer, and internal Service Line Protection Plans. The Group operates its businesses mainly through one reportable segment, the Regulated Utility segment.
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.